Clever Leaves Strengthens Leadership Team and Appoints Hank Hague as Chief Financial Officer
22 Februar 2021 - 2:00PM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”
or the “Company”), a leading multi-national operator and licensed
producer of pharmaceutical-grade cannabinoids, announced today the
appointment of Hank Hague as its new Chief Financial Officer,
effective immediately.
Mr. Hague joins Clever Leaves with extensive
experience in providing financial leadership to various public and
private entities in the pharmaceutical, biomedical, and cannabis
industries. Most recently, Mr. Hague served as CEO at Aidance
Scientific, an FDA-registered manufacturer of branded and private
label OTC topical medications. Prior to this role, Mr. Hague was
CFO of Abacus Health Products, Inc. (“Abacus”) where he led the
company’s public listing and the acquisition and integration of
Harmony Hemp. Mr. Hague also managed the due diligence and sale
process of Abacus to hemp-derived wellness product producer and
distributor, Charlotte’s Web Holdings, Inc. Additionally, at
Abacus, Mr. Hague assisted with the strategy that placed one of the
first OTC CBD products sold at a national retailer and assisted
with brand development for Abacus’ brand, CBDMedic. Mr. Hague has
also held CFO roles at Foster Corporation and Scott Brass.
“We are thrilled to welcome Hank to the Clever
Leaves team. Hank has an impressive corporate background and he has
demonstrated exceptional financial and strategic leadership in his
previous roles,” commented Kyle Detwiler, CEO of Clever Leaves.
“Hank will be an invaluable asset as our company continues to
expand our global commercial footprint and distribution
network.”
“Clever Leaves’ broad international reach, and
extensive partnership portfolio make the company well positioned to
capitalize on the massive potential of the medical cannabis
market,” said Mr. Hague. “Together with this experienced leadership
team, I look forward to applying my financial leadership experience
in the cannabis and pharmaceutical industries as Clever Leaves
enters its next phase of growth.”
Hague steps in for Amit Pandey, who has served
as Clever Leaves’ interim CFO since December 18, 2020. Clever
Leaves thanks Mr. Pandey for his leadership, which included
assisting Clever Leaves through its public listing on the Nasdaq in
December 2020. Mr. Pandey will continue to support Mr. Hague and
the global finance team in his newly appointed role as Executive
Vice President of Finance.
About Clever Leaves Holdings Inc.
Clever Leaves is a multi-national cannabis
company with an emphasis on ecologically sustainable, large-scale
cultivation and pharmaceutical-grade processing as the cornerstones
of its global cannabis business. With operations and investments in
the United States, Canada, Colombia, Germany and Portugal, Clever
Leaves has created an effective distribution network and global
footprint, with a foundation built upon capital efficiency and
rapid growth. Clever Leaves aims to be one of the industry’s
leading global cannabis companies recognized for its principles,
people, and performance while fostering a healthier global
community. Clever Leaves has received multiple international
certifications that have enabled it to increase its export and
sales capacity from its Colombian operations, including European
Union Good Manufacturing Practices (EU GMP) Certification, a Good
Manufacturing Practices (GMP) Certification by Colombia National
Food and Drug Surveillance Institute - Invima, and Good
Agricultural and Collecting Practices (GACP) Certification. Clever
Leaves was granted a provisional license in Portugal from Infarmed
– the Portuguese health authority – that allows Clever Leaves to
cultivate, import and export dry flower for medicinal and research
purposes.
For more information, please visit
https://cleverleaves.com/en/home/
Forward-Looking StatementsThis
press release includes certain statements that are not historical
facts but are forward-looking statements for purposes of the safe
harbor provisions under the United States Private Securities
Litigation Reform Act of 1995. Forward-looking statements generally
are accompanied by words such as “aim,” “anticipate,” “believe,”
“continue,” “estimate,” “expect,” “forecasts,” “future,” “intend,”
“may,” “outlook,” “plan,” “potential,” “predict,” “projected,”
“seek,” “seem,” “should,” “will,” “would” and similar expressions
(or the negative versions of such words or expressions) that
predict or indicate future events or trends or that are not
statements of historical matters. Such forward-looking statements
are subject to risks and uncertainties, which could cause actual
results to differ from the forward-looking statements. Factors that
may cause such differences include, without limitation,
expectations with respect to future operating and financial
performance and growth, including if or when Clever Leaves will
become profitable; the trading price of Clever Leaves securities;
Clever Leaves’ ability to execute its business plans and strategy
and to receive regulatory approvals; potential litigations; global
economic conditions; geopolitical events, natural disasters, acts
of God and pandemics, including, but not limited to, the economic
and operational disruptions and other effects of COVID-19;
regulatory requirements and changes thereto; and access to
additional financing. The foregoing list of factors is not
exclusive. Additional information concerning certain of these and
other risk factors is contained in Clever Leaves’ most recent
filings with the SEC. All subsequent written and oral
forward-looking statements concerning Clever Leaves and
attributable to Clever Leaves or any person acting on its behalf
are expressly qualified in their entirety by the cautionary
statements above. Readers are cautioned not to place undue reliance
upon any forward-looking statements, which speak only as of the
date made. Clever Leaves expressly disclaims any obligations or
undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change
in its expectations with respect thereto or any change in events,
conditions or circumstances on which any statement is based.
Clever Leaves Press
contacts:McKenna MillerKCSA Strategic
Communications+1347-487-6197mmiller@kcsa.com
Diana SigüenzaStrategic Communications
Director+57310-236-8830Diana.siguenza@cleverleaves.com
Clever Leaves Investor
inquiries:Sean Mansouri, CFA or Cody SlachGateway Investor
Relations+1949-574-3860CLVR@gatewayir.com
Clever Leaves Commercial
inquiries:Andrew MillerVice President Sales - EMEA, North
America, and
Asia-Pacific+1416-817-1336andrew.miller@cleverleaves.com
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024